Predictors and moderators of burden of care and emotional distress in first-episode psychosis caregivers: results from the GET UP pragmatic cluster randomised controlled trial.


Journal

Epidemiology and psychiatric sciences
ISSN: 2045-7979
Titre abrégé: Epidemiol Psychiatr Sci
Pays: England
ID NLM: 101561091

Informations de publication

Date de publication:
10 Apr 2019
Historique:
pubmed: 11 4 2019
medline: 22 5 2020
entrez: 11 4 2019
Statut: epublish

Résumé

First-episode psychosis (FEP) is a major life event and can have an adverse impact on the diagnosed individual and their families. The importance of intervening early and providing optimal treatments is widely acknowledged. In comparison to patient groups, literature is scarce on identifying treatment predictors and moderators of caregiver outcomes. This study aimed to identify pre-treatment characteristics predicting and/or moderating carer outcomes, based on data from a multi-element psychosocial intervention to FEP patients and carers (GET-UP PIANO trial). Carer demography, type of family relationship, patient contact hours, pre-treatment carer burden, patient perceptions of parental caregiving and expressed emotion (EE) were selected, a priori, as potential predictors/moderators of carer burden and emotional distress at 9 months post treatment. Outcomes were analysed separately in mixed-effects random regression models. Analyses were performed on 260 carers. Only patient perceptions of early maternal criticism predicted reports of lower carer burden at follow-up. However, multiple imputation analysis failed to confirm this result. For treatment moderators: higher levels of carer burden at baseline yielded greater reductions in carer emotional distress at follow-up in the experimental group compared with treatment as usual (TAU). Higher levels of perceived EE moderated greater reductions in carer reports of tension in experimental group, compared with TAU, at follow-up. In younger caregivers (<51 years old), there were greater reductions in levels of worry during the baseline to follow-up period, within the experimental group compared with TAU. The study failed to identify significant treatment predictors of FEP carer outcomes. However, our preliminary findings suggest that optimal treatment outcomes for carers at first episode might be moderated by younger carer age, and carers reporting higher baseline levels of burden, and where patients perceive higher levels of negative effect from caregivers.

Identifiants

pubmed: 30968810
pii: S2045796019000155
doi: 10.1017/S2045796019000155
pmc: PMC8061200
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e27

Références

Br J Psychiatry. 1998 Jul;173:61-8
pubmed: 9850205
Aust N Z J Psychiatry. 2016 May;50(5):410-72
pubmed: 27106681
Soc Psychiatry Psychiatr Epidemiol. 1991 May;26(3):132-8
pubmed: 1887291
Am J Psychiatry. 2017 Nov 1;174(11):1075-1085
pubmed: 27978770
Am J Psychiatry. 2005 Dec;162(12):2220-32
pubmed: 16330584
J Child Psychol Psychiatry. 1994 Nov;35(8):1419-35
pubmed: 7868637
Psychol Med. 1997 Jan;27(1):191-7
pubmed: 9122299
Front Psychol. 2017 May 16;8:721
pubmed: 28559862
Can J Psychiatry. 2008 Jul;53(7):460-8
pubmed: 18674404
Psychiatry Res. 2014 Aug 15;218(1-2):48-53
pubmed: 24768246
Psychol Med. 1994 Aug;24(3):707-18
pubmed: 7991753
Compr Psychiatry. 2015 Oct;62:1-12
pubmed: 26343461
Clin Psychol Rev. 2013 Apr;33(3):372-82
pubmed: 23410719
Asian J Psychiatr. 2017 Feb;25:163-168
pubmed: 28262142
Soc Psychiatry Psychiatr Epidemiol. 2001 Nov;36(11):537-44
pubmed: 11824848
Trials. 2012 May 30;13:73
pubmed: 22647399
Schizophr Bull. 2014 Apr;40 Suppl 3:S165-94
pubmed: 24778411
J Nerv Ment Dis. 2014 Jun;202(6):432-9
pubmed: 24821278
Community Ment Health J. 2015 Jul;51(5):591-7
pubmed: 25690154
Schizophr Bull. 2010 Jan;36(1):94-103
pubmed: 19955388
Arch Gen Psychiatry. 2002 Oct;59(10):877-83
pubmed: 12365874
Psychol Med. 2000 Jul;30(4):823-9
pubmed: 11037090
Schizophr Bull. 2015 Nov;41(6):1403-12
pubmed: 25925392
Br J Psychiatry Suppl. 2005 Aug;48:s59-64
pubmed: 16055810
Soc Psychiatry Psychiatr Epidemiol. 2014 Mar;49(3):367-76
pubmed: 24081324
Acta Psychiatr Scand. 1994 Dec;90(6):432-7
pubmed: 7892776
BMC Psychiatry. 2017 Mar 21;17(1):102
pubmed: 28320339
Psychol Med. 2010 Jan;40(1):63-72
pubmed: 19079825
Epidemiol Psychiatr Sci. 2019 Dec;28(6):613-629
pubmed: 29893656
Pharmacoeconomics. 2008;26(2):149-62
pubmed: 18198934
Acta Psychiatr Scand. 2003 Oct;108(4):285-9
pubmed: 12956829
Clin Psychol Rev. 2003 Nov;23(6):849-80
pubmed: 14529701
BMC Psychiatry. 2015 Jul 21;15:162
pubmed: 26194890
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
J Nerv Ment Dis. 2015 May;203(5):379-86
pubmed: 25900547
Clin Psychol Rev. 2015 Feb;35:56-66
pubmed: 25531423
Psychol Psychother. 2013 Jun;86(2):197-211
pubmed: 23674469
Br J Psychiatry. 2016 Sep;209(3):186-8
pubmed: 27587758
Arch Gen Psychiatry. 1999 Mar;56(3):241-7
pubmed: 10078501
Br J Psychiatry. 2017 May;210(5):342-349
pubmed: 28302703
J Nerv Ment Dis. 2014 Nov;202(11):783-7
pubmed: 25259947
Psychiatr Serv. 2015 Jul;66(7):680-90
pubmed: 25772766
Soc Psychiatry Psychiatr Epidemiol. 2013 Sep;48(9):1377-88
pubmed: 23407901
Schizophr Res. 2013 May;146(1-3):118-24
pubmed: 23490761
Schizophr Bull. 2011 Mar;37(2):381-8
pubmed: 19679716
BMJ. 2012 Sep 04;345:e5661
pubmed: 22951546
Br J Soc Clin Psychol. 1976 Jun;15(2):157-65
pubmed: 938822
Early Interv Psychiatry. 2017 Jun;11(3):237-243
pubmed: 25721376
Soc Psychiatry Psychiatr Epidemiol. 2013 Feb;48(2):325-35
pubmed: 22648702
BMC Psychiatry. 2014 Jun 09;14:171
pubmed: 24913656
Schizophr Res. 2018 Sep;199:346-352
pubmed: 29661524
Br J Psychiatry. 2015 Aug;207(2):135-42
pubmed: 25999336
Br J Psychiatry. 2004 Apr;184:321-6
pubmed: 15056576
Epidemiol Psychiatr Sci. 2017 Jun;26(3):265-275
pubmed: 26847994
Psychiatry Res. 2007 May 30;151(1-2):97-106
pubmed: 17376540
Can J Psychiatry. 2017 Sep;62(9):617-623
pubmed: 28703017
J Nerv Ment Dis. 2009 Feb;197(2):85-91
pubmed: 19214042
J Clin Psychol. 1988 May;44(3):392-7
pubmed: 3384966
Br J Psychiatry Suppl. 2000;(39):s21-7
pubmed: 10945074
Br J Psychiatry. 2008 Jun;192(6):412-23
pubmed: 18515890
Br J Psychiatry. 1998 Aug;173:139-44
pubmed: 9850226
Schizophr Res. 2012 Apr;136(1-3):7-12
pubmed: 22336955
Soc Psychiatry Psychiatr Epidemiol. 2015 Mar;50(3):371-8
pubmed: 25053150
Acta Psychiatr Scand. 1998 Jan;97(1):76-85
pubmed: 9504708
J Psychiatr Res. 2013 Feb;47(2):208-14
pubmed: 23158233
Schizophr Bull. 2015 Sep;41(5):1192-203
pubmed: 25995057
Aust N Z J Psychiatry. 2012 Jan;46(1):35-9
pubmed: 22247091
J Clin Psychol. 1993 Mar;49(2):216-8
pubmed: 8098049
Schizophr Res. 2005 Dec 15;80(2-3):227-34
pubmed: 15964175
Early Interv Psychiatry. 2014 May;8(2):122-9
pubmed: 23458284
Soc Psychiatry Psychiatr Epidemiol. 2016 Apr;51(4):513-20
pubmed: 26724945

Auteurs

J Onwumere (J)

Department of Psychology, King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, England.

C Bonetto (C)

Section of Psychiatry, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

A Lasalvia (A)

Unit of Psychiatry, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

E Miglietta (E)

Section of Psychiatry, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

A Veronese (A)

Department of Neurosciences, University of Padova and Azienda Ospedaliera, Padua, Italy.

F Bellini (F)

Department of Mental Health, Azienda USL Romagna, CMHC Riccione, Italy.

M Imbesi (M)

Department of Mental Health, Azienda USL, Piacenza, Italy.

P Bebbington (P)

Department of Psychiatry, University College London, London, England.

E Kuipers (E)

Department of Psychology, King's College London, Institute of Psychiatry, Psychology & Neuroscience, London, England.

M Ruggeri (M)

Section of Psychiatry, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH